Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Change in Cash (2016 - 2025)

Historic Change in Cash for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to -$1.7 million.

  • Lemaitre Vascular's Change in Cash fell 3283.35% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 5230.51%. This contributed to the annual value of $1.3 million for FY2024, which is 7388.51% down from last year.
  • According to the latest figures from Q3 2025, Lemaitre Vascular's Change in Cash is -$1.7 million, which was down 3283.35% from $1.8 million recorded in Q2 2025.
  • Lemaitre Vascular's 5-year Change in Cash high stood at $6.2 million for Q4 2023, and its period low was -$4.3 million during Q2 2024.
  • Its 5-year average for Change in Cash is -$66842.1, with a median of -$1.3 million in 2024.
  • In the last 5 years, Lemaitre Vascular's Change in Cash plummeted by 28467.93% in 2021 and then skyrocketed by 36350.81% in 2022.
  • Lemaitre Vascular's Change in Cash (Quarter) stood at -$3.5 million in 2021, then soared by 163.2% to $2.2 million in 2022, then skyrocketed by 179.96% to $6.2 million in 2023, then fell by 25.88% to $4.6 million in 2024, then plummeted by 136.52% to -$1.7 million in 2025.
  • Its Change in Cash was -$1.7 million in Q3 2025, compared to $1.8 million in Q2 2025 and -$270000.0 in Q1 2025.